TB-01 CD200 CHECKPOINT BLOCKADE PLAYS AN IMPORTANT ROLE IN CNS TUMOR IMMUNOEDITING

Por Moertel, Christopher, Pluhar, Elizabeth, Olin, Michael
Publicado no Neuro Oncol (2016)

TMOD-25. PEPTIDES OF IMMUNE CHECKPOINT PROTEIN, CD200 (OX2), ENHANCES THE RESPONSE TO VACCINE-BASED IMMUNOTHERAPY IN DOGS WITH HIGH-GRADE GLIOMA

Por Pluhar, Elizabeth, Olin, Michael, Hunt, Matthew
Publicado no Neuro Oncol (2017)

Use of CD200 blockade inhibitor to enhance glioma immunotherapy

Por Mesias, Elisabet, Xiong, Zhengming, Pluhar, Elizabeth, Olin, Michael
Publicado no J Immunother Cancer (2015)

IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT

Por Ampudia-Mesias, Elisabet, Moertel, Christopher, Pluhar, Elizabeth, Olin, Michael
Publicado no Neuro Oncol (2017)

IMMU-11. TARGETING THE CD200 CHECKPOINT BLOCKADE: A NEW DIRECTION FOR IMMUNOTHERAPY

Por Olin, Michael, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pluhar, Elizabeth, Moertel, Christopher
Publicado no Neuro Oncol (2017)

Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints

Por Kiefer, Kristina M., O'Brien, Timothy D., Pluhar, Elizabeth G., Conzemius, Michael
Publicado no Vet Rec Open (2015)